California agency endows Geron with $25 million for stem cell trial
This article was originally published in Scrip
Executive Summary
Geron won a $25 million award from the California Institute for Regenerative Medicine (CIRM) – the state's stem cell agency – to support clinical development of the biotech's human embryonic stem cell (hESC) therapy GRNOPC1, which currently is being tested in a Phase I trial in patients with spinal cord injury.